Beta-blockers and reverse remodeling: what are the implications?

Am Heart J. 2003 Feb;145(2):200-2. doi: 10.1067/mhj.2003.106.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Cardiomyopathy, Dilated / drug therapy
  • Cardiomyopathy, Dilated / physiopathology
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Humans
  • Stroke Volume / drug effects
  • Stroke Volume / physiology
  • Treatment Outcome
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Remodeling*

Substances

  • Adrenergic beta-Antagonists